Received Jun 9, 2025
| Type | Name | Manufacturer | Dose | Lot | Route / Site |
|---|---|---|---|---|---|
| MMRV | MEASLES + MUMPS + RUBELLA + VARICELLA (PROQUAD) | MERCK & CO. INC. | UNK | Y010930 | — |
No symptoms reported.; HCP reported a lot of PROQUAD was administered on 23MAY2025 after the product experienced a temperature excursion on 19MAY2025.; This spontaneous report was received from a registered nurse and refers to a patient of unknown age and gender. The patient's medical history, concurrent conditions and concomitant therapies were not reported. On 19-MAY-2025, a temperature excursion occurred at a temperature of 10.5 Fahrenheit during a time frame of 1 hour. On 23-May-2025, the patient was vaccinated with an improperly storage dose of Measles, Mumps, Rubella and Varicella (Oka-Merck) Virus Vaccine Live (PROQUAD), 0.5 mL, lot #Y010930; which has been verified to be valid for Measles, Mumps, Rubella and Varicella (Oka-Merck) Virus Vaccine Live, expiration date reported and upon internal validation establish as 14-DEC-2025 and with the sterile diluent (BAXTER STERILE DILUENT) 0.5 mL, lot #1950636; which has been verified to be valid, expiration date reported and upon internal validation establish as 22-JAN-2026, 0.5 mL, both administered for prophylaxis (dose number, vaccination site scheme, route and anatomical site of administration were not provided) (Product storage error). No previous temperature excursion. No symptoms reported (No adverse event).
Diluent Mrk